Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Journal of Women'S Health (2002)|August 12, 2024
Initiation of Oral Endocrine Therapy and Survival Benefit Among Women with Early-Stage Breast CancerJingjing Qian, Bang Truong
Expert Opinion on Biological Therapy|March 9, 2023
Adverse event reporting of marketed biosimilar and biological monoclonal antibody cancer treatments in the United StatesXiangzhong Xue, Bang Truong, Jingjing Qian
Beilstein Journal of Nanotechnology|September 7, 2023
Ni, Co, Zn, and Cu metal-organic framework-based nanomaterials for electrochemical reduction of CO2: A reviewHa Huu Do, Hai Bang Truong
Cancer Causes & Control : CCC|September 8, 2023
Factors associated with adherence to medications for lowering breast cancer risk between female Medicare beneficiaries in Alabama and nationwideJingjing Qian, Bang Truong, Kaniz Afroz Tanni
Journal of Environmental Management|September 2, 2023
Recent advances in g-C3N4-based photocatalysis for water treatment: Magnetic and floating photocatalysts, and applications of machine-learning techniquesHai Bang Truong, Xuan Cuong Nguyen, Jin Hur
Beilstein Journal of Nanotechnology|September 28, 2023
Metal-organic framework-based nanomaterials for CO2 storage: A reviewHa Huu Do, Iqra Rabani, Hai Bang Truong
Expert Opinion on Drug Safety|February 12, 2021
Comparisons of adverse event reporting for colistin versus polymyxin B using the US Food and Drug Administration Adverse Event Reporting System (FAERS)Cong Bang Truong, Spencer H Durham, Jingjing Qian
The American Journal of Managed Care|October 23, 2023
Use of second-generation antidiabetic medication among a nationally representative sampleBang Truong, Yuexin Li, Jingyi Zheng, et al.
Chemosphere|August 5, 2021
Advances in application of g-C3N4-based materials for treatment of polluted water and wastewater via activation of oxidants and photoelectrocatalysis: A comprehensive reviewHai Bang Truong, Sungjun Bae, Jinwoo Cho, et al.
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 13, 2021
Safety of Marketed Cancer Supportive Care Biosimilars in the US: A Disproportionality Analysis Using the Food and Drug Administration Adverse Event Reporting System (FAERS) DatabaseKaniz Afroz Tanni, Cong Bang Truong, Sura Almahasis, et al.
Pageof 5